Literature DB >> 27358871

Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.

Tianyu Guo1, Xuejun Wang1, Yigong Qu1, Yu Yin1, Tao Jing1, Qing Zhang1.   

Abstract

Hematopoietic stem cells (HSCs) undergo successive lineage commitment steps to generate megakaryocytes (MKs) in a process referred to as megakaryopoiesis. MKs undergo a unique differentiation process involving endomitosis to eventually produce platelets. Many transcription factors participate in the regulation of this complex progress. Chemokines and other factors in the microenvironment where megakaryopoiesis and platelet production occur play vital roles in the regulation of HSC lineage commitment and MK maturation; among these factors, thrombopoietin (TPO) is the most important. Endomitosis is a vital process of MK maturation, and granules that are formed in MKs are important for platelet function. Proplatelets are firstly generated from mature MKs and then become platelets. The proplatelet production process was verified by novel studies that revealed that the mechanism is partially regulated by the invaginated membrane system (IMS), microtubules and Rho GTPases. The extracellular matrices (ECMs) and shear stress also affect and regulate the process while the mature MKs migrate from the marrow to the sub-endothelium region near the venous sinusoids leading to the release of platelets into the circulation. This review describes the entire process of megakaryopoiesis in detail, illustrates both the transcriptional and microenvironmental regulation of MKs and provides insight into platelet biogenesis.

Entities:  

Keywords:  Hematopoietic stem cells (HSCs); endomitosis; megakaryopoiesis; microenvironment; platelet production

Year:  2015        PMID: 27358871      PMCID: PMC4923649          DOI: 10.3978/j.issn.2306-9759.2015.02.01

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  85 in total

1.  Endomitotic megakaryocytes form a midzone in anaphase but have a deficiency in cleavage furrow formation.

Authors:  Amy E Geddis; Kenneth Kaushansky
Journal:  Cell Cycle       Date:  2006-03-01       Impact factor: 4.534

Review 2.  Apoptotic processes in megakaryocytes and platelets.

Authors:  Michael J White; Benjamin T Kile
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

3.  Membrane surface specialization of blood platelet and megakaryocyte.

Authors:  K Nakao; A A Angrist
Journal:  Nature       Date:  1968-03-09       Impact factor: 49.962

4.  The role of Rab38 in platelet dense granule defects.

Authors:  I Ninkovic; J G White; A Rangel-Filho; Y H Datta
Journal:  J Thromb Haemost       Date:  2008-10-01       Impact factor: 5.824

5.  Single-cell phenotyping within transparent intact tissue through whole-body clearing.

Authors:  Bin Yang; Jennifer B Treweek; Rajan P Kulkarni; Benjamin E Deverman; Chun-Kan Chen; Eric Lubeck; Sheel Shah; Long Cai; Viviana Gradinaru
Journal:  Cell       Date:  2014-07-31       Impact factor: 41.582

6.  The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.

Authors:  Denisa Urban; Ling Li; Hilary Christensen; Fred G Pluthero; Shao Zun Chen; Michael Puhacz; Parvesh M Garg; Kiran K Lanka; James J Cummings; Helmut Kramer; James D Wasmuth; John Parkinson; Walter H A Kahr
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

7.  Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Authors:  Hui Huang; Ming Yu; Thomas E Akie; Tyler B Moran; Andrew J Woo; Nathan Tu; Zachary Waldon; Yin Yin Lin; Hanno Steen; Alan B Cantor
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

8.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.

Authors:  Motoshi Ichikawa; Takashi Asai; Toshiki Saito; Sachiko Seo; Ieharu Yamazaki; Tetsuya Yamagata; Kinuko Mitani; Shigeru Chiba; Seishi Ogawa; Mineo Kurokawa; Hisamaru Hirai
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

Review 9.  Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.

Authors:  Rodney P DeKoter; Meghana B Kamath; Isaac B Houston
Journal:  Blood Cells Mol Dis       Date:  2007-07-13       Impact factor: 3.039

10.  Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death.

Authors:  Murray C H Clarke; John Savill; David B Jones; Brendon S Noble; Simon B Brown
Journal:  J Cell Biol       Date:  2003-02-17       Impact factor: 10.539

View more
  15 in total

1.  Engineered platelets with antithrombotic and antimetastatic properties.

Authors:  Liuting Yu; Zhizhuang Joe Zhao
Journal:  Stem Cell Investig       Date:  2019-09-02

Review 2.  The Role of Megakaryocytes in Myelofibrosis.

Authors:  Johanna Melo-Cardenas; Anna Rita Migliaccio; John D Crispino
Journal:  Hematol Oncol Clin North Am       Date:  2021-01-11       Impact factor: 3.722

3.  C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis.

Authors:  Takahiro Kumode; Hirokazu Tanaka; Jorge Luis Esipinoza; Shinya Rai; Yasuhiro Taniguchi; Ryosuke Fujiwara; Keigo Sano; Kentaro Serizawa; Yoshio Iwata; Yasuyoshi Morita; Itaru Matsumura
Journal:  Int J Hematol       Date:  2022-02-01       Impact factor: 2.490

4.  Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient.

Authors:  Akira Sakamaki; Takayuki Watanabe; Satoshi Abe; Kenya Kamimura; Atsunori Tsuchiya; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2017-03-21

Review 5.  On the Way to in vitro Platelet Production.

Authors:  Catherine Strassel; Christian Gachet; François Lanza
Journal:  Front Med (Lausanne)       Date:  2018-08-28

6.  Integrated Network Pharmacology and Metabolomics Analysis of the Therapeutic Effects of Zi Dian Fang on Immune Thrombocytopenic Purpura.

Authors:  Yubo Li; Yamei Li; Wenliang Lu; Hongbin Li; Yuming Wang; Houmin Luo; Yuanyuan Wu; Wenying Dong; Gang Bai; Yanjun Zhang
Journal:  Front Pharmacol       Date:  2018-06-19       Impact factor: 5.810

Review 7.  Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis.

Authors:  Marion Mussbacher; Manuel Salzmann; Christine Brostjan; Bastian Hoesel; Christian Schoergenhofer; Hannes Datler; Philipp Hohensinner; José Basílio; Peter Petzelbauer; Alice Assinger; Johannes A Schmid
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

Review 8.  Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Physiol Rev       Date:  2020-10-30       Impact factor: 37.312

9.  MicroRNA Microarray Profiling during Megakaryocyte Differentiation of Cord Blood CD133+ Hematopoietic Stem Cells.

Authors:  Mohammad Houshmand; Mozhde Nakhlestani Hagh; Masoud Soleimani; Amir Ali Hamidieh; Saeed Abroun; Mahin Nikougoftar Zarif
Journal:  Cell J       Date:  2018-03-18       Impact factor: 2.479

10.  Developments in the production of platelets from stem cells (Review).

Authors:  Jie Yang; Jianfeng Luan; Yanfei Shen; Baoan Chen
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.